Annual Total Debt
$2.62 M
-$128.40 M-98.00%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual total debt is $2.62 million, with the most recent change of -$128.40 million (-98.00%) on December 31, 2023.
- During the last 3 years, AVDL annual total debt has fallen by -$127.90 million (-97.99%).
- AVDL annual total debt is now -98.19% below its all-time high of $145.00 million, reached on December 31, 2021.
Performance
AVDL Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.94 M
-$233.00 K-10.72%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly total debt is $1.94 million, with the most recent change of -$233.00 thousand (-10.72%) on September 30, 2024.
- Over the past year, AVDL quarterly total debt has dropped by -$683.00 thousand (-26.03%).
- AVDL quarterly total debt is now -98.70% below its all-time high of $149.69 million, reached on June 30, 2015.
Performance
AVDL Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
AVDL Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -98.0% | -26.0% |
3 y3 years | -98.0% | -91.2% |
5 y5 years | -97.7% | -91.2% |
AVDL Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -98.2% | at low | -98.7% | at low |
5 y | 5-year | -98.2% | at low | -98.7% | at low |
alltime | all time | -98.2% | +882.8% | -98.7% | -100.0% |
Avadel Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.94 M(-10.7%) |
Jun 2024 | - | $2.17 M(-9.5%) |
Mar 2024 | - | $2.40 M(-8.5%) |
Dec 2023 | $2.62 M(-98.0%) | $2.62 M(-89.1%) |
Sep 2023 | - | $24.03 M(+8.6%) |
Jun 2023 | - | $22.12 M(-80.8%) |
Mar 2023 | - | $115.16 M(-12.1%) |
Dec 2022 | $131.02 M(-9.6%) | $131.02 M(-5.2%) |
Sep 2022 | - | $138.27 M(+1.3%) |
Jun 2022 | - | $136.51 M(-5.9%) |
Mar 2022 | - | $145.13 M(+0.1%) |
Dec 2021 | $145.00 M(+11.1%) | $145.00 M(+0.7%) |
Sep 2021 | - | $144.05 M(+0.1%) |
Jun 2021 | - | $143.86 M(+0.1%) |
Mar 2021 | - | $143.66 M(+10.1%) |
Dec 2020 | $130.52 M(+4.7%) | $130.52 M(+1.2%) |
Sep 2020 | - | $129.01 M(+1.2%) |
Jun 2020 | - | $127.53 M(+1.2%) |
Mar 2020 | - | $126.07 M(+1.1%) |
Dec 2019 | $124.65 M(+7.6%) | $124.65 M(+0.0%) |
Sep 2019 | - | $124.63 M(+1.0%) |
Jun 2019 | - | $123.35 M(+1.0%) |
Mar 2019 | - | $122.15 M(+5.4%) |
Dec 2018 | $115.84 M(>+9900.0%) | $115.84 M(+1.2%) |
Sep 2018 | - | $114.49 M(+1.2%) |
Jun 2018 | - | $113.15 M(+1.2%) |
Mar 2018 | - | $111.84 M(>+9900.0%) |
Dec 2017 | $267.00 K(-67.2%) | $267.00 K(-70.8%) |
Sep 2017 | - | $915.00 K(+3.4%) |
Jun 2017 | - | $885.00 K(+7.0%) |
Mar 2017 | - | $827.00 K(+1.5%) |
Dec 2016 | $815.00 K(-27.1%) | $815.00 K(-20.1%) |
Sep 2016 | - | $1.02 M(-4.8%) |
Jun 2016 | - | $1.07 M(-8.0%) |
Mar 2016 | - | $1.16 M(+4.1%) |
Dec 2015 | $1.12 M(-69.9%) | $1.12 M(>+9900.0%) |
Sep 2015 | - | $0.00(-100.0%) |
Jun 2015 | - | $149.69 M(+21.5%) |
Mar 2015 | - | $123.19 M(+3214.1%) |
Dec 2014 | $3.72 M(-95.7%) | $3.72 M(-96.1%) |
Sep 2014 | - | $95.95 M(+9.5%) |
Jun 2014 | - | $87.59 M(+17.1%) |
Mar 2014 | - | $74.82 M(-12.5%) |
Dec 2013 | $85.55 M(+131.9%) | $85.55 M(-0.5%) |
Sep 2013 | - | $85.97 M(+1.2%) |
Jun 2013 | - | $84.99 M(+56.6%) |
Mar 2013 | - | $54.26 M(+47.1%) |
Dec 2012 | $36.88 M(+807.8%) | $36.88 M(>+9900.0%) |
Sep 2012 | - | $0.00(-100.0%) |
Jun 2012 | - | $50.10 M(-0.2%) |
Mar 2012 | - | $50.18 M(+1135.1%) |
Dec 2011 | $4.06 M(+0.2%) | $4.06 M(-3.1%) |
Sep 2011 | - | $4.20 M(+0.9%) |
Jun 2011 | - | $4.16 M(-6.7%) |
Mar 2011 | - | $4.46 M(+9.8%) |
Dec 2010 | $4.06 M | $4.06 M(+1.0%) |
Sep 2010 | - | $4.02 M(+11.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2010 | - | $3.62 M(-0.7%) |
Mar 2010 | - | $3.65 M(-6.6%) |
Dec 2009 | $3.90 M(+25.2%) | $3.90 M(+21.5%) |
Sep 2009 | - | $3.21 M(+3.4%) |
Jun 2009 | - | $3.11 M(+6.0%) |
Mar 2009 | - | $2.93 M(-5.9%) |
Dec 2008 | $3.12 M(-8.9%) | $3.12 M(-3.8%) |
Sep 2008 | - | $3.24 M(-10.5%) |
Jun 2008 | - | $3.62 M(+1.5%) |
Mar 2008 | - | $3.57 M(+4.2%) |
Dec 2007 | $3.42 M(-1.8%) | $3.42 M(+0.3%) |
Sep 2007 | - | $3.42 M(+1.7%) |
Jun 2007 | - | $3.36 M(-1.6%) |
Mar 2007 | - | $3.41 M(-2.1%) |
Dec 2006 | $3.49 M(-8.0%) | $3.49 M(+1.1%) |
Sep 2006 | - | $3.45 M(-3.1%) |
Jun 2006 | - | $3.56 M(-1.0%) |
Mar 2006 | - | $3.60 M(-5.1%) |
Dec 2005 | $3.79 M(+29.4%) | $3.79 M(-15.1%) |
Sep 2005 | - | $4.46 M(+58.7%) |
Jun 2005 | - | $2.81 M(-9.8%) |
Mar 2005 | - | $3.12 M(+6.4%) |
Dec 2004 | $2.93 M(+33.6%) | $2.93 M(+31.7%) |
Sep 2004 | - | $2.22 M(0.0%) |
Jun 2004 | - | $2.22 M(+6.3%) |
Mar 2004 | - | $2.09 M(-4.6%) |
Dec 2003 | $2.19 M(-10.9%) | $2.19 M(+20.0%) |
Sep 2003 | - | $1.83 M(-3.1%) |
Jun 2003 | - | $1.89 M(+1.9%) |
Mar 2003 | - | $1.85 M(-24.8%) |
Dec 2002 | $2.46 M(+45.2%) | $2.46 M(+20.1%) |
Sep 2002 | - | $2.05 M(>+9900.0%) |
Jun 2002 | - | $0.00(0.0%) |
Mar 2002 | - | $0.00(-100.0%) |
Dec 2001 | $1.70 M(-23.6%) | $1.70 M(>+9900.0%) |
Sep 2001 | - | $0.00(0.0%) |
Jun 2001 | - | $0.00(0.0%) |
Mar 2001 | - | $0.00(-100.0%) |
Dec 2000 | $2.22 M(-15.8%) | $2.22 M(>+9900.0%) |
Sep 2000 | - | $0.00(0.0%) |
Jun 2000 | - | $0.00(0.0%) |
Mar 2000 | - | $0.00(-100.0%) |
Dec 1999 | $2.64 M(-20.5%) | $2.64 M(>+9900.0%) |
Sep 1999 | - | $0.00(0.0%) |
Jun 1999 | - | $0.00(0.0%) |
Mar 1999 | - | $0.00(-100.0%) |
Dec 1998 | $3.32 M(-2.4%) | $3.32 M(>+9900.0%) |
Sep 1998 | - | $0.00(0.0%) |
Jun 1998 | - | $0.00(-100.0%) |
Mar 1998 | - | $3.30 M(-2.9%) |
Dec 1997 | $3.40 M(+61.9%) | $3.40 M(>+9900.0%) |
Sep 1997 | - | $0.00(0.0%) |
Jun 1997 | - | $0.00(0.0%) |
Mar 1997 | - | $0.00(-100.0%) |
Dec 1996 | $2.10 M | $2.10 M(>+9900.0%) |
Sep 1996 | - | $0.00(0.0%) |
Jun 1996 | - | $0.00(-100.0%) |
Mar 1996 | - | $2.00 M |
FAQ
- What is Avadel Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual total debt year-on-year change?
- What is Avadel Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly total debt year-on-year change?
What is Avadel Pharmaceuticals annual total debt?
The current annual total debt of AVDL is $2.62 M
What is the all time high annual total debt for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual total debt is $145.00 M
What is Avadel Pharmaceuticals annual total debt year-on-year change?
Over the past year, AVDL annual total debt has changed by -$128.40 M (-98.00%)
What is Avadel Pharmaceuticals quarterly total debt?
The current quarterly total debt of AVDL is $1.94 M
What is the all time high quarterly total debt for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly total debt is $149.69 M
What is Avadel Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, AVDL quarterly total debt has changed by -$683.00 K (-26.03%)